Soberlink, a leader in real-time mobile-breath sobriety technology, announced that the Soberlink Breathalyzer has received 510(k) premarket clearance from the U.S. Food and Drug Administration (FDA) for medical use by healthcare providers to remotely measure alcohol in human breath. The device will aid in the detection and monitoring of alcohol consumption in those who suffer from alcohol use disorders.

Soberlink and Sober Sky Web Portal act as an accountability tool that allows recovering individuals to conveniently and discreetly share blood alcohol content (BAC) results with their treatment providers and recovery circle from almost anywhere in the world. Soberlink has worked for over five years with the top treatment facilities and addiction experts to develop a protocol for using the Soberlink System in clinical monitoring of alcohol use disorders.

The longer a person stays involved with consistent monitoring, the better the long-term outcome. The traditional standard of care for alcohol monitoring has been urinalysis testing. With the Soberlink Cellular Device and Sober Sky Web Portal, testing is no longer confined to a laboratory environment. The flexibility of the Soberlink System and partnership with Verizon Wireless empowers individuals to test from nearly anywhere and at any time.

Soberlink
soberlink.com